Učitavanje...
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma
The GAUDI study assessed safety and preliminary efficacy of induction therapy with obinutuzumab plus chemotherapy, followed by maintenance therapy with obinutuzumab alone, in previously untreated patients with follicular lymphoma. Assignment to chemotherapy was decided on a per-center basis before t...
Spremljeno u:
Izdano u: | Haematologica |
---|---|
Glavni autori: | , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Ferrata Storti Foundation
2017
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5395117/ https://ncbi.nlm.nih.gov/pubmed/28011903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.152272 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|